NCT00119587View on ClinicalTrials.gov

Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2002

Study Completion Date

September 30, 2003

Conditions

Anemia

Interventions

DRUG

darbepoetin alfa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY

NCT00119587 - Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects | Biotech Hunter | Biotech Hunter